Literature DB >> 7945354

Characterization of the mechanism of cellular and cell free protein synthesis inhibition by an anti-tumor ribonuclease.

J J Lin1, D L Newton, S M Mikulski, H F Kung, R J Youle, S M Rybak.   

Abstract

Onconase, a protein with anti-tumor activity, causes potent inhibition of protein synthesis in the rabbit reticulocyte lysate (IC50 10(-11) M) and when microinjected into Xenopus oocytes (IC50 10(-10) M). Onconase is a member of the RNase A superfamily; however, unlike RNase A, the mechanism of protein synthesis inhibition does not involve apparent degradation of lysate or cellular ribosomal RNAs. Rather, reticulocyte and oocyte tRNA is hydrolyzed after Onconase treatment. Furthermore, re-addition of tRNA to Onconase pretreated lysates or oocytes restores the translational capacity of the system. Taken together these results suggest that Onconase causes potent protein synthesis inhibition by a mechanism involving inactivation of cellular tRNA.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7945354     DOI: 10.1006/bbrc.1994.2439

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  13 in total

1.  Induction of differentiation of leukaemic (HL-60) or prostate cancer (LNCaP, JCA-1) cells potentiates apoptosis triggered by onconase.

Authors:  H D Halicka; T Murakami; C N Papageorgio; A Mittelman; S M Mikulski; K Shogen; Z Darzynkiewicz
Journal:  Cell Prolif       Date:  2000-12       Impact factor: 6.831

Review 2.  Cancer chemotherapy--ribonucleases to the rescue.

Authors:  P A Leland; R T Raines
Journal:  Chem Biol       Date:  2001-05

3.  Binding assay and preliminary X-ray crystallographic analysis of ACTIBIND, a protein with anticarcinogenic and antiangiogenic activities.

Authors:  Marina de Leeuw; Levava Roiz; Patricia Smirnoff; Betty Schwartz; Oded Shoseyov; Orna Almog
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2007-07-28

4.  The nucleic acid binding activity of bleomycin hydrolase is involved in bleomycin detoxification.

Authors:  W Zheng; S A Johnston
Journal:  Mol Cell Biol       Date:  1998-06       Impact factor: 4.272

Review 5.  tRNA and cytochrome c in cell death and beyond.

Authors:  Yide Mei; Jeongsik Yong; Aaron Stonestrom; Xiaolu Yang
Journal:  Cell Cycle       Date:  2010-08-07       Impact factor: 4.534

6.  Essential stations in the intracellular pathway of cytotoxic bovine seminal ribonuclease.

Authors:  Aurora Bracale; Daniela Spalletti-Cernia; Mariarosaria Mastronicola; Francesco Castaldi; Roberta Mannucci; Lucio Nitsch; Giuseppe D'Alessio
Journal:  Biochem J       Date:  2002-03-15       Impact factor: 3.857

Review 7.  Onconase and amphinase, the antitumor ribonucleases from Rana pipiens oocytes.

Authors:  W Ardelt; K Shogen; Z Darzynkiewicz
Journal:  Curr Pharm Biotechnol       Date:  2008-06       Impact factor: 2.837

8.  Onconase responsive genes in human mesothelioma cells: implications for an RNA damaging therapeutic agent.

Authors:  Deborah A Altomare; Susanna M Rybak; Jianming Pei; Jacob V Maizel; Mitchell Cheung; Joseph R Testa; Kuslima Shogen
Journal:  BMC Cancer       Date:  2010-02-05       Impact factor: 4.430

Review 9.  Ribonucleases as potential modalities in anticancer therapy.

Authors:  Wojciech Ardelt; Barbara Ardelt; Zbigniew Darzynkiewicz
Journal:  Eur J Pharmacol       Date:  2009-10-14       Impact factor: 4.432

10.  Ribonuclease inhibitor as an intracellular sentry.

Authors:  Marcia C Haigis; Erin L Kurten; Ronald T Raines
Journal:  Nucleic Acids Res       Date:  2003-02-01       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.